SCHEMBL5339170

SCHEMBL5339170

N#Cc1ccc(-c2cnc(Nc3ccc4[nH]ncc4c3)o2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 4/20 0.53
KDR P35968 4/20 0.53
FLT4 P35916 3/20 0.53
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
ROCK2 O75116 2/20 0.46
IMPDH2 P12268 5/20 0.46
PIK3CA P42336 1/20 0.45
MKNK1 Q9BUB5 1/20 0.43
MAPKAPK2 P49137 1/20 0.42
AURKA O14965 1/20 0.42
DAPK3 O43293 1/20 0.42
JAK2 O60674 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
PAK4 O96013 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
CSF1R P07333 1/20 0.42
RET P07949 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5340970 0.88 FLT1 (0.61) FLT1KDRFLT4MAOAMAOB
SCHEMBL5333863 0.85 VCP (0.58) FLT1KDRFLT4ROCK2IMPDH2
SCHEMBL5335613 0.85 CDC7 (0.58) FLT1KDRFLT4MAOBROCK2
SCHEMBL5333205 0.85 IMPDH2 (0.53) FLT1KDRFLT4ROCK2IMPDH2
SCHEMBL5316809 0.85 NOS1 (0.48) FLT1KDRFLT4ROCK2IMPDH2
SCHEMBL5343891 0.85 VCP (0.58) FLT1KDRFLT4ROCK2IMPDH2
SCHEMBL5336433 0.85 MKNK1 (0.51) FLT1KDRFLT4ROCK2IMPDH2
SCHEMBL5336680 0.85 IMPDH2 (0.59) FLT1KDRFLT4IMPDH2PIK3CA
SCHEMBL14465941 0.85 IMPDH2 (0.61) FLT1KDRFLT4IMPDH2PIK3CA
SCHEMBL5318416 0.82 TNIK (0.60) FLT1KDRFLT4ROCK2IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO claimed
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO disclosed
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO disclosed